Atherogenic lipoprotein phenotype in end-stage renal failure: Origin and extent of small dense low-density lipoprotein formation
- 1 May 2000
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 35 (5) , 852-862
- https://doi.org/10.1016/s0272-6386(00)70255-1
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycansAtherosclerosis, 1996
- Low-density lipoprotein particle size distribution in end-stage renal disease treated with hemodialysis or peritoneal dialysisAmerican Journal of Kidney Diseases, 1996
- Increased Activity of Plasma Cholesteryl Ester Transfer Protein in Children with End-Stage Renal Disease Receiving Continuous Ambulatory Peritoneal DialysisNephron, 1996
- Relations Between Plasma Lipids and Postheparin Plasma Lipases and VLDL and LDL Subfraction Patterns in Normolipemic Men and WomenArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Evidence that reduced lipoprotein lipase activity is not a primary pathogenetic factor for hypertriglyceridemia in renal failureKidney International, 1995
- Heterogeneity of plasma low-density lipoproteins and atherosclerosis riskCurrent Opinion in Lipidology, 1994
- Metabolism of apolipoprotein B-containing lipoproteins in subjects with nephrotic-range proteinuriaKidney International, 1991
- Kinetics of peritoneal protein loss during CAPD: I. Different characteristics for low and high molecular weight proteinsKidney International, 1990
- Hyperapobetalipoproteinemia: the major dyslipoproteinemia in patients with chronic renal failure treated with chronic ambulatory peritoneal dialysisAtherosclerosis, 1987
- Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis.Journal of Clinical Investigation, 1986